Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Айконик Терапьютикс, Инк.filedCriticalАйконик Терапьютикс, Инк.
Priority claimed from PCT/US2019/012427external-prioritypatent/WO2019136309A1/en
Publication of EA202091631A1publicationCriticalpatent/EA202091631A1/en
В изобретении предложены антитела, которые специфически связываются с тканевым фактором человека (TF - англ.: tissue factor), конъюгаты антитело к TF-лекарственное средство (ADC - англ.: antibody-drug conjugates) и композиции, содержащие антитела или ADC. В изобретении также предложены способы получения и применения антител или ADC, такие как терапевтические и диагностические способы.The invention provides antibodies that specifically bind to human tissue factor (TF), anti-TF-drug conjugates (ADC) and compositions containing antibodies or ADCs. The invention also provides methods of making and using antibodies or ADCs, such as therapeutic and diagnostic methods.
EA202091631A2018-08-022019-01-04
ANTIBODIES TO TISSUE FACTOR, ANTIBODY-DRUG CONJUGATES AND RELATED METHODS
EA202091631A1
(en)